sisunatovir
Showing 1 - 13 of 13
Healthy Trial in Brussels (Sisunatovir, Rabeprazole)
Not yet recruiting
- Healthy
- Sisunatovir
- Rabeprazole
-
Brussels, Bruxelles-capitale, Région DE, BelgiumPfizer Clinical Research Unit - Brussels
Oct 24, 2023
Healthy Trial (sisunatovir)
Not yet recruiting
- Healthy
- sisunatovir
- (no location specified)
Aug 8, 2023
Respiratory Syncytial Virus Infection Trial in Shanghai (Sisunatovir)
Not yet recruiting
- Respiratory Syncytial Virus Infection
- Sisunatovir
-
Shanghai, Shanghai, ChinaHuashan Hospital
Aug 4, 2023
Respiratory Syncytial Virus Infection Trial (Sisunatovir, Placebo)
Not yet recruiting
- Respiratory Syncytial Virus Infection
- Sisunatovir
- Placebo
- (no location specified)
Oct 6, 2023
Respiratory Syncytial Viruses Trial (sisunatovir, Placebo)
Not yet recruiting
- Respiratory Syncytial Viruses
- sisunatovir
- Placebo
- (no location specified)
Jan 25, 2023
Healthy Trial in New Haven (sisunatovir, , moxifloxacin)
Recruiting
- Healthy
- sisunatovir
- +2 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
May 18, 2023
Respiratory Syncytial Virus Infections Trial (Placebo, Active)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- Placebo
- Active
- (no location specified)
Oct 20, 2023
Respiratory Syncytial Virus Infections Trial in Baltimore (200 mg RV521/78 µCi [ 14C]-RV521.)
Completed
- Respiratory Syncytial Virus Infections
- 200 mg RV521/78 µCi [ 14C]-RV521.
-
Baltimore, MarylandPharmaron Clinical Pharmacology Center
May 15, 2023
Renal Impairment Trial (Drug: PF-07923568)
Not yet recruiting
- Renal Impairment
- Drug: PF-07923568
- (no location specified)
Sep 7, 2023
Liver Diseases, Hepatic Impairment Trial (PF-07923568)
Not yet recruiting
- Liver Diseases
- Hepatic Impairment
- (no location specified)
May 4, 2023
Respiratory Syncytial Virus (RSV), Lower Resp Tract Infection Trial in Worldwide (RV521, Placebo)
Recruiting
- Respiratory Syncytial Virus (RSV)
- Lower Resp Tract Infection
- RV521
- Placebo
-
Buenos Aires, Argentina
- +45 more
Jan 21, 2022
Respiratory Syncytial Virus Infections Trial in London (RV521)
Completed
- Respiratory Syncytial Virus Infections
-
London, United KingdomRichmond Pharmacology Ltd
Dec 30, 2019
Healthy Trial in Brussels (Sinsunatovir, Bitrex)
Recruiting
- Healthy
- Sinsunatovir
- Bitrex
-
Brussels, Bruxelles-capitale, Région DE, BelgiumPfizer Clinical Research Unit - Brussels
Aug 15, 2023